Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

This Week's Healthcare Earnings: UnitedHealth, HCA, J&J No Photo Available

Yeji Jesse Lee

It was a week of good news and bad news for the healthcare industry. Earnings season kicked off when three companies posted financials... (more story)

Texas AG's Vaccine Probe Draws Fire From Health Experts No Photo Available

Hannah Albarazi

Public health experts are condemning a Texas Attorney General inquiry into Pfizer, UnitedHealth Group and others for allegedly tapping... (more story)

Biotech Fundraising A Good Sign For Public Markets No Photo Available

Yeji Jesse Lee

At the start of what many healthcare attorneys hope will be a busy year, public biotechs are raising cash, signaling a thawing public ... (more story)